Tradestie Institutional Equity Comparison Engine

TMO vs LZAGY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TMO Overall Edge

TMO Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Thermo Fisher Scientific, Inc. (TMO) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TMO trades at 24.1x Forward P/E with 19.1% operating margin (+9.1% YoY revenue) versus LZAGY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, TMO sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against LZAGY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner TMO
TMO 24.1x vs LZAGY N/M Fwd P/E
Growth & Margin Winner TMO
Op Margin 19.1% vs N/A ยท YoY +9.1% vs N/A
Momentum & Technical Winner TMO
1Y +16.7% vs +16.5% ยท 52W Pos 80% vs 77%
Options & Structure Winner TMO
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
TMO NYSE
Thermo Fisher Scientific, Inc.
Measuring & Controlling Devices, Nec
$669.54
-2.79% 1D
Market Cap $255.2B
1M Return -1.03%
1Y Return +16.69%
Forward P/E 24.1x
Unified AI Score
51.5 / 100 HOLD
Tech 39.0 Fund 48.0 Flow 57.0 Mom 50.0
LZAGY US Equity
LZAGY
Institutional Equity
$77.10
-2.58% 1D
Market Cap N/A
1M Return +0.53%
1Y Return +16.54%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 18.0 Fund 39.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: TMO +16.69% LZAGY +16.54% Spread: +0.15 pp (TMO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
TMO TTM Op. Margin: 19.1% LZAGY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TMO vs LZAGY. Trailing 12-month operating profitability (TMO 19.1% vs LZAGY N/A) and valuation multiples (TMO 24.1x vs LZAGY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: TMO (9) vs LZAGY (1)
Institutional Metric TMO LZAGY Criterion Row Winner
Market Capitalization Scale $255.2B N/A Larger Scale TMO
Trailing P/E Ratio Valuation 36.3x N/M Lower Multiple TMO
Forward P/E Ratio Valuation 24.1x N/M Lower Multiple TMO
Revenue Growth (YoY) Growth +9.1% N/A Higher Growth TMO
Operating Margin (TTM) Profitability 19.1% N/A Higher Margin TMO
Net Profit Margin Profitability 14.9% N/A Higher Margin TMO
Return on Equity (ROE) Capital Efficiency 13.4% N/A Higher ROE TMO
52-Week Range Position Momentum 80% ($435โ€“$728) 77% ($59โ€“$83) Stronger Trend TMO
Beta / 30D Volatility Risk Regime 0.58ฮฒ ยท 30% Vol 0.45ฮฒ ยท 17% Vol Lower Realized Risk LZAGY
Unified Institutional Score Composite Signal 51.5 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite TMO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full TMO vs LZAGY Buy Guide
TMO CONSOLIDATION
48d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live TMO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LZAGY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LZAGY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither TMO nor LZAGY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.